Monday, November 4, 2024
HomeTagsClinical-stage biotechnology

clinical-stage biotechnology

Vaccinex Announces Pricing of $9.6 Million Public Offering

Vaccinex, Inc., a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease and cancer through the inhibition of SEMA4D,  announced it has...

Celyad Oncology Announces FDA Lifts Clinical Hold of CYAD-101-002 Phase 1b Trial

Celyad Oncology SA, a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer,...

Stealth BioTherapeutics Corp Announces Receipt of Preliminary Non-Binding Proposal

Stealth BioTherapeutics Corp, a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction, announced that...

Molecure to Regain Worldwide Rights to Dual Chitinase Inhibitor OATD-01

Molecure S.A. a clinical stage biotechnology company that uses its world leading medicinal capabilities to discover and develop first in class small molecule drug...

Kineta Presents New Preclinical Data and Phase 1/2 Clinical Trial Design of KVA12.1 at the Tumor Myeloid-Directed Therapies Summit

Kineta, Inc. ("Kineta" or the "Company"), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology, announced that it presented the...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics